PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Fatty liver linked to increased risk of death from several diseases

2025-03-24
(Press-News.org) A comprehensive study from Karolinska Institutet shows that people with fatty liver disease have almost twice the mortality rate of the general population. They have an increased risk of dying from both liver diseases and common diseases such as cancer and cardiovascular disease, according to the study published in The Journal of Hepatology.

It is estimated that one in five people in Sweden has fatty liver disease known as MASLD (metabolic dysfunction-associated steatotic liver disease), and globally it may be as many as one in four. The disease is caused by overweight or obesity and is characterised by an excessive accumulation of fat in the liver, which can lead to severe liver damage and liver cancer.

Hidden health condition

“Many people are not aware that they have fatty liver disease because it rarely causes any symptoms in the earlier stages,” says Axel Wester, assistant professor at the Department of Medicine, Huddinge, Karolinska Institutet and physician at Karolinska University Hospital. “Our study shows that people diagnosed with MASLD have an increased risk of dying from many different diseases, not just liver disease.”

The researchers identified all patients diagnosed with MASLD in Sweden between 2002 and 2020, more than 13,000 patients in total, and analysed their risk of death from different causes compared to the general population.

The overall mortality rate for people with MASLD was almost twice as high. The risk was elevated for nearly all causes of death studied, but especially for death from liver disease (27 times higher mortality) and liver cancer (35 times higher mortality). However, the most common causes of death were cardiovascular disease and non-liver cancer, with mortality rates 54 and 47 per cent higher, respectively.

A holistic approach

People with MASLD also had an increased risk of dying from infections, gastrointestinal diseases, respiratory diseases, endocrine diseases or external causes, but not from mental illness.

“It is important that we do not only focus on the liver when treating patients with fatty liver disease,” says Hannes Hagström, adjunct professor at the Department of Medicine, Huddinge, Karolinska Institutet and senior physician at Karolinska University Hospital. “A holistic approach and early intervention involving different medical specialities can be crucial to improve the prognosis for these patients.”

The study was led by Hannes Hagström and Axel Wester who share the last authorship, while Gabriel Issa, a medical student at Karolinska Institutet, is the first author. The research was funded by the Swedish Research Council, the Swedish Cancer Society, Region Stockholm, Syskonen Svensson Foundation for Medical Research, Mag-Tarmfonden, the Bengt Ihre Foundation, the Professor Nanna Svartz Foundation and the Gastroenterological Research Fund (the Swedish Society of Medicine). Hannes Hagström’s institutions have received research funding from Astra Zeneca, EchoSens, Gilead, Intercept, MSD and Pfizer. He has also been a consultant for Astra Zeneca and has been part of hepatic events adjudication committees for KOWA, GW Pharma, Boehringer Ingelheim and Arrowhead.

Publication: “Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden”, Gabriel Issa, Ying Shang, Rickard Strandberg, Hannes Hagström, Axel Wester, The Journal of Hepatology, online 24 March 2025, doi: 10.1016/j.jhep.2025.03.001.

More reading (in-depth article on ki.se): Long live the liver!

END


ELSE PRESS RELEASES FROM THIS DATE:

Do lifetime body weight patterns affect kidney cancer risk?

2025-03-24
Excess weight in mid-life is a known risk factor for kidney cancer, but new research indicates that weight patterns throughout life may also affect an individual’s likelihood of developing this malignancy. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society. To assess weight patterns and their associations with kidney cancer and its different subtypes, investigators analyzed information on 204,364 individuals from the NIH-AARP Diet and Health Study, including body mass index (BMI) data when participants entered the study (an average age of 61.6 years), and prior BMI recordings at 18, 35, and 50 ...

AI can predict premature deaths in people with inflammatory bowel disease

2025-03-24
Almost half of people who died with inflammatory bowel disease (IBD) died prematurely, according to a study published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.241117 that used machine learning models to predict death. Canada has some of the highest rates of IBD worldwide, which includes Crohn disease and ulcerative colitis. People with IBD have shorter life expectancy than people without such diseases, and they can develop other chronic health conditions related to their IBD. The study found that people with IBD are at risk for premature death (defined ...

Household electricity three times more expensive than upcoming ‘eco-friendly’ aviation e-fuels, study reveals

2025-03-24
Existing tax policies during the energy transition from fossil fuels to renewable sources will lead to major energy injustices and skewed priorities, new research published in Climate Policy shows. The peer-reviewed study found that electricity serving primary needs, such as heating or lighting, ultimately costs three times more than electricity for tertiary needs such as long-distance mobility – mostly due to taxation policies. Further highlighting the ongoing social inequalities of fuel and related policies, the findings also demonstrate within the European Union (EU), the wealthiest 1% of all its population is responsible for 66% of the distance ...

Urine test could halve post-op scans for kidney cancer

2025-03-24
A simple urine test could accurately show the recurrence of kidney cancer at an early stage, potentially sparing patients invasive scans and enabling faster access to treatment, new research has shown. The findings are presented today [Monday 24 March 2025] at the European Association of Urology (EAU) Congress in Madrid and have been accepted for publication in European Urology Oncology. The test analyses the distinctive profiles of certain types of sugar molecules, called glycosaminoglycans which are found in urine. These profiles are known as the GAGome. The international AURORAX-0087A (AUR87A) study is assessing whether a GAGome test can accurately detect ...

Thousands of lives could be saved by combining two cholesterol-lowering drugs

Thousands of lives could be saved by combining two cholesterol-lowering drugs
2025-03-23
London, UK: The largest analysis to examine the best way to lower levels of ‘bad’ cholesterol in patients with blocked arteries shows that they should immediately be given a combination of a statin and another drug called ezetimibe, rather than statins alone. This could prevent thousands of deaths a year from heart attacks, strokes and other cardiovascular diseases. The meta-analysis of 108,353 patients in 14 studies who were at very high risk of suffering heart attack or stroke, or who had already suffered one of these cardiovascular events is published in the journal Mayo Clinic Proceedings ...

High resolution ultrasound could enable faster prostate cancer diagnosis

2025-03-23
Biopsies guided by high resolution ultrasound are as effective as those using MRI in diagnosing prostate cancer, an international clinical trial has shown. The technology, called micro-ultrasound, is cheaper and easier to use than MRI. It could significantly speed up diagnosis, reduce the need for multiple hospital visits and free up MRI for other uses, researchers say. The results of the OPTIMUM trial are presented today [Sunday 23 March 2025] at the European Association of Urology Congress in Madrid and published in JAMA. OPTIMUM is the first randomised trial to compare micro-ultrasound (microUS) guided biopsy with ...

Guardians of the vineyard: Canines and chemistry work to combat powdery mildew

2025-03-23
SAN DIEGO, March 23, 2025 — Dogs have many jobs but one you may not expect is identifying grapevines coated in a destructive and highly contagious fungus. Although dogs can detect serious vine infections by smell, scientists don’t know exactly what odor molecules are triggering the response. Researchers are now analyzing volatile chemicals emanating from grape leaves infected by a fungus called powdery mildew with the goal of improving training for vineyard canines. Nayelly Rangel, a graduate student at Texas Tech University, will present the team’s results at the spring meeting of the American Chemical Society (ACS). ACS Spring 2025 is being held ...

Improving GLP-1 drug delivery by ‘painting’ it on antibodies

2025-03-23
SAN DIEGO, March 23, 2025 — Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss. Unfortunately, shortages and high costs have made it difficult for people to start and maintain treatment. Now, researchers report a drug delivery system that “paints” these peptides directly on the antibodies they target. In studies with mice, the system led to sustained weight loss and prolonged blood sugar management with a GLP-1 injection one fourth that of the standard dose. Bradley Pentelute, professor of chemistry at the Massachusetts Institute of Technology (MIT), will present his team’s results at the spring ...

Second TB vaccination boosts immunity in bladder cancer patients and reduces cancer recurrence

2025-03-23
Two doses of a simple tuberculosis vaccination after surgery helps the immune system fight cancer cells and could greatly improve patient outcomes for the most common type of bladder cancer, according to a pilot study of 40 patients. Initial results from the RUTIVAC-1 Trial are presented today [Sunday 23 March 2025] at the European Association of Urology (EAU) Congress in Madrid. In the randomised controlled trial, administering the vaccine alongside standard treatment led to an elevated immune response, which is known to improve the body’s ability to suppress future tumours. Patients who received the vaccine had no discernible ...

Study of UK biobank reveals link between new-onset type 2 diabetes and some but not all obesity-related cancers

2025-03-22
New research to be presented at this year’s European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that a new diagnosis of type 2 diabetes is linked to a subsequent increase in the risk of developing some, but not all, obesity related cancers. The study is by Owen Tipping, University of Manchester, UK, and Professor Andrew Renehan, National Institute for Health Research (NIHR) Manchester Biomedical Research Centre, Manchester, UK, and colleagues. Previous research has described associations between type 2 diabetes mellitus (T2D) and higher risk of several obesity-related cancers ...

LAST 30 PRESS RELEASES:

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

Mission accomplished for the “T2T” Hong Kong Bauhinia Genome Project

Study identifies how malaria can lead to childhood cancer

An earth-abundant mineral for sustainable spintronics

[Press-News.org] Fatty liver linked to increased risk of death from several diseases